CorVel (NASDAQ:CRVL) Director R Judd Jessup Sells 4,023 Shares

CorVel Corp. (NASDAQ:CRVL) Director R. Jessup sold 4,023 shares of the firm’s stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $70.07, for a total value of $281,891.61. Following the completion of the transaction, the director directly owned 111,798 shares in the company, valued at $7,833,685.86. The trade was a 3.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

R Judd Jessup also recently made the following trade(s):

• On Thursday, August 27th, R. Jessup sold 1,262 shares of CorVel stock. The stock was sold at an average price of $70.64, for a total transaction of $89,147.68.
• On Wednesday, August 26th, R. Jessup sold 1,562 shares of CorVel stock. The stock was sold at an average price of $70.71, for a total value of $110,449.02.

CorVel Stock Down 2.4%

NASDAQ CRVL opened at $68.68 on Friday. The company has a market capitalization of $3.50 billion, a P/E ratio of 30.52 and a beta of 0.97. The stock’s 50-day moving average price is $64.14 and its 200-day moving average price is $58.93. CorVel Corp. has a 52 week low of $44.83 and a 52 week high of $93.45.

CorVel (NASDAQ:CRVL) last announced its quarterly earnings data on Tuesday, August 4th. The business services provider reported $0.63 EPS for the quarter. CorVel had a return on equity of 29.92% and a net margin of 11.72%.The business had revenue of $259.93 million for the quarter.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on CRVL shares. Weiss Ratings upgraded CorVel from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday. Wall Street Zen raised CorVel from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has an average rating of “Hold”.

Institutional Trading of CorVel

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CRVL. Walleye Capital LLC bought a new position in shares of CorVel during the second quarter valued at approximately $3,308,000. NewEdge Wealth LLC bought a new position in CorVel in the second quarter worth approximately $1,956,000. Callan Family Office LLC bought a new position in CorVel in the second quarter worth approximately $3,833,000. Deutsche Bank AG purchased a new stake in CorVel during the second quarter worth $3,772,000. Finally, BlackRock Inc. purchased a new stake in CorVel during the second quarter worth $321,316,000. 51.36% of the stock is owned by hedge funds and other institutional investors.

About CorVel

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).